Showing results (2011-2020 of 2,319) with videos related to

Sort By:
Pageof 232
In Vivo (Athens, Greece)|September 3, 2020
Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addictedDavid Rossi, Paolo Lippe, Marco Bruno Luigi Rocchi, et al.
Obesity Surgery|August 8, 2025
Intragastric Balloon for Treatment of Overweight and Obesity: Which Is the Best Filling Volume? A Single-Center Randomized StudySalvatore Francesco Vadalà di Prampero, Ica Bassu, Marcello Fiorani, et al.
Genome Research|August 10, 2011
Copy number variation analysis in the great apes reveals species-specific patterns of structural variationElodie Gazave, Fleur Darré, Carlos Morcillo-Suarez, et al.
BMJ (Clinical Research Ed.)|January 22, 2000
Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in ChildrenS Conroy, I Choonara, P Impicciatore, et al.
Environmental Pollution (Barking, Essex : 1987)|May 10, 2025
One Health approach and tiered strategy to assess anticoagulant rodenticides exposure in red foxes (Vulpes vulpes) from Central ItalyRachele Rocchi, Federica Castellani, Romolo Salini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2015
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple MyelomaElena Zamagni, Cristina Nanni, Katia Mancuso, et al.
Cancer Investigation|June 2, 2000
Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancerS Cascinu, M Ligi, E Del Ferro, et al.
Cancers|April 14, 2025
Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct GenotypeMichela Rondoni, Giovanni Marconi, Annalisa Nicoletti, et al.
Scientific Reports|March 7, 2013
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiologyStefania Romeo, Cristina Viaggi, Daniela Di Camillo, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reasonGiammarco Mocci, Arianna Cingolani, Giorgia Orrù, et al.
Pageof 232